Quotes About Pharmaceutical

Your client is losing about twenty million a day in revenue because Krayoxx is no longer on the market

This change to a higher phase of alert is a signal to governments, to ministries of health and other ministries, to the pharmaceutical industry and the business community that certain actions now should be undertaken with increased urgency and at an accelerated pace.

And it should not come as no shock that Big Food, along with the pharmaceutical industry and its scientists for hire, has promoted confusion in the media and in the mind of the American consumer to contribute to our culture of overconsumption.

Medication is an incredibly attractive concept. Not just for the person with depression, or the person running a pharmaceutical firm, but for society as a whole. It underlines the idea we have hammered into us by the hundred thousand TV ads we have seen that everything can be fixed by consuming things.

The pharmaceutical industry is considered one of the most profitable and politically powerful industries in the United States, and mental illness is considered a golden goose: chronic, common, and often treated with multiple drugs.76 Indeed, antidepressants are currently prescribed to more than 8 percent of the population.77

The first time I met and embraced Judy Garland, it made pharmaceutical history.

expectations, in fact, are so powerful that placebos (fake treatments like sugar pills, saline injections, and sham surgery) cause bald men to grow hair, high blood pressure to drop, ulcers to heal, dopamine levels to increase, and even tumors to shrink. And although pharmaceutical companies would rather keep this on the down low, placebos relieve symptoms on par with real medication. In other words, it's our beliefs that do the healing.

Roche offered a different interpretation: while it might be true that some patients appeared to be abusing Librium and Valium, these were people who were using the drug in a nontherapeutic manner. Some individuals just have addictive personalities and are prone to abuse any substance you make available to them. This attitude was typical in the pharmaceutical industry: it's not the drugs that are bad; it's the people who abuse them.

But, as Wilson pointed out, "once a company gets approval for a drug, a doctor can prescribe it for anything they want.

In 1996, Purdue had introduced a groundbreaking drug, a powerful opioid painkiller called OxyContin, which was heralded as a revolutionary way to treat chronic pain. The drug became one of the biggest blockbusters in pharmaceutical history, generating some $35 billion in revenue.

When a pharmaceutical company releases a new drug, they have a big launch meeting, which can seem like some unholy combination of a bachelor party, a marketing convention, and a revival meeting.

As for Curtis Wright, he had been giving some thought, lately, to leaving the federal government. After the approval for OxyContin went through, he resigned from the FDA. Initially, he joined a small pharmaceutical firm in Pennsylvania called Adolor. But he did not stay long. Barely a year later, he moved on, to a new position at Purdue Pharma, in Norwalk, with a first-year compensation package of nearly $400,000.

As I make clear throughout the book, OxyContin was hardly the only opioid to be fraudulently marketed or widely abused, and my choice to focus on Purdue is in no way a suggestion that other pharmaceutical companies do not deserve a great deal of blame for the crisis. The same could be said for the FDA, the doctors who wrote prescriptions, the wholesalers that distributed the opioids, and the pharmacies that filled the prescriptions.

But as it happened, a team of chemists in Germany had recently managed to refine morphine into a new drug, heroin, which the German pharmaceutical company Bayer began to mass market as a wonder drug—a safer alternative to morphine. Heroin was created by the same research team that invented aspirin.

It is clear that the pharmaceutical industry is not, by any stretch of the imagination, doing enough to ensure that the poor have access to adequate medical care.

The FDA constantly approves drugs—not necessarily because they're helpful to the patient but because they bring in money and profits to the huge pharmaceutical industry. True, some of the drugs extend the life of cancer patients—but none of them cure cancer.

Growth in this business is driven by exposure to emerging markets, and we'd plan to keep expanding that. One of the neat things about this company is that it's very diversified already in terms of geography, with a significant presence in Latin America, China and the Middle East. In many of those regions there is an increasing use of pharmaceutical and dietary products, so we see a long-term secular uplift from that.